Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses. Issues relating to drug treatment for methamphetamine abuse.
H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses H.R. 5678, Universal Access to Methamphetamine Treatment Act of 2010, issues relating to treatment for methamphetamine misuse Issues relating to Appropriations for the National Youth Anti-Drug Media Campaign
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2010 · second_quarter · 2A
H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses H.R. 5678, Universal Access to Methamphetamine Treatment Act of 2010, issues relating to treatment for methamphetamine misuse Issues relating to Appropriations for the National Youth Anti-Drug Media Campaign
Filing targets: HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2010 · first_quarter · Q1
Source: Senate LDA
Universal Access to Methamphetamine Treatment Act of 2010
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses H.R. 5678, Universal Access to Methamphetamine Treatment Act of 2010, issues relating to treatment for methamphetamine misuse Issues relating to Appropriations for the National Youth Anti-Drug Media Campaign
H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses. Issues relating to drug treatment for methamphetamine abuse.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE